There are a whole class of medications that are insulin sensitizers, so perhaps we can develop medications that will allow people to be sensitized to GLP-1s or find formulations of GLP-1, like the longer-acting versions, that avoid the GLP-1 resistance, she said
The good news is that forward-thinking institutions are already creating specialized training programs
A 2026 UK review of the histamine-and-wakefulness science, the hippocampal-prefrontal evidence, the anticholinergic-burden & dementia question, why non-drowsy antihistamines come first and why treating the allergy, not a peptide, comes first Read the full review Autoimmune & Cognitive Neuroscience 23 June 2026 Dihexa for Sjgrens Syndrome Brain Fog: Sjgrens Fog, the Ianalumab NEPTUNUS Phase 3, Nipocalimab DAHLIAS & the 2026 UK Review My eyes and mouth are dry but its the fog thats wrecking my life. Up to 500,000 people in the UK live with Sjgrens the second most common autoimmune rheumatic disease after rheumatoid arthritis and brain fog and fatigue routinely rank above dryness for what disrupts daily life, with measurable cognitive impairment in ~4450%
What prompted closer scrutiny in recent years is that NAION appeared in some people while they were taking semaglutide
For temperature-sensitive compounds like MOTS-C, that chain of custody matters for maintaining peptide integrity and ensuring accurate dosing
Projected approval path: If Phase III trials confirm safety and effectiveness, Cagrilintide will likely be submitted for regulatory approval as a prescription obesity treatment in the next few years